Europe Medical Cannabis Market - Industry Trends and Forecast to 2029

Segmentation

Short Description
Europe Medical Cannabis Market, By Product (Oil, Dried Medial Cannabis, Medical Cannabis Capsules, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer and Others), Source (Synthetic and Natural), Species (Cannabis Indica, Sativa and Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease/Migranes, Epilepsy, Depression and Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals and Others) (End User (Pharmaceutical Industry, Research and Development Centers, Homecare Settings, Hospital and Rehab Centers and Others), Distribution Channel (B2B and B2C), Country (Germany, U.K., Italy, Netherlands, Switzerland, France, Russia, Spain, Belgium and Rest of Europe) Industry Trends and Forecast to 2029

Market Definition:

 Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has a wide range of applications in the treatment of various diseases, including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS, and Alzheimers, among others.
Medical marijuana has also been legalized in other EU member states, most recently in France, Romania, and the Czech Republic. For instance, the use of Sativex has been approved in 17 European countries, nine of which have already made it available.
Legal cannabis is one of the fastest fastest-growing industries in European states, with major implications for food and beverage, textile, chemical, and many other industries. For thousands of years, hemp seeds have been used as a nutritional food. These seeds contain very fewer levels of THC (-9-tetrahydrocannabinol), and hence, they are different from medicinal marijuana.
The hemp seeds are processed to take out hemp oil, while the left residue is used as a protein protein-rich food. The hemp seeds proteins have a high level of arginine and sulfur-rich amino acids among others. Therefore, they can be used as functional foods.
The hemp seed derivatives as oil possess various good qualities as they act as antioxidants that which is why they are used to make a lot of food products.
Market Segmentation:
The Europe medical cannabis market is categorized into eight segments: product, source, species, derivative, and application, route of administration, end user, and distribution channel.
 On the basis of product, Europe medical cannabis market is segmented into oil, medical cannabis capsules, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, among others
 On the basis of source, Europe medical cannabis market is segmented into synthetic and natural
 On the basis of species, Europe medical cannabis market is segmented into Cannabis indica, Sativa, and hybrid
 On the basis of derivative, Europe medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, and others
 On the basis of application, Europe medical cannabis market is segmented into pain management, anxiety, muscle spasms, nausea, appetite loss, cancer, arthritis, Alzheimers disease/migraines, epilepsy, depression and sleep disorders, multiple sclerosis, autism, mental health conditions, elevate mood and others
 On the basis of route of administration, Europe medical cannabis market is segmented into oral solutions and capsules, smoking, vaporizers, topicals, and others
 On the basis of end user, Europe medical cannabis market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital, rehab centers, and others
 On the basis of distribution channel, Europe medical cannabis market is segmented into B2B and B2C

Market Players

Some of the major players operating in the market are:

 Tilray
 Medipharm Labs Inc.
 Althea Company Pty Ltd
 PharmaHemp
 Aurora Cannabis.
 Elixinol Global Limited
 CANOPY GROWTH CORPORATION
 Jazz Pharmaceuticals Inc.
 ECOGEN BIOSCIENCES
 Little Green Pharma
 GRASS & CO.
 CANNARAY
 Sanity Group GmbH.
 VIVO Cannabis Inc.
 HEXO Corp.
 Marrican Inc.

Methodology